APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Josamycin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Josamycin Industry Growth and Trends Forecast to 2032

Report ID 174005400122 December 2025107 pages

Choose your research edition.

Industry ResearchJosamycin Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Josamycin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Josamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Josamycin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Josamycin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Josamycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Josamycin include Tosun Pharm, CSPC, SINE, Minsheng Pharma, BioChemPartner, Guilin Pharma, Bayer, Guanghua Pharma and SAJA Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Josamycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Josamycin market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Josamycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Josamycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Josamycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Josamycin Market by Company

Tosun Pharm

CSPC

SINE

Minsheng Pharma

BioChemPartner

Guilin Pharma

Bayer

Guanghua Pharma

SAJA Pharma

Ferrer International

Dragon Pharm

Astellas

Josamycin Segment by Type

99% Purity Type

98% Purity Type

95% Purity Type

Others

Josamycin Segment by Application

Josamycin Tablets

Propidinium Propionate Granule

Others

Josamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Josamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Josamycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Josamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 99% Purity Type Table 2. Major Company of 98% Purity Type Table 3. Major Company of 95% Purity Type Table 4. Major Company of Others Table 5. Global Josamycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Josamycin Sales by Type (2021-2026) & (tons) Table 7. Global Josamycin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Josamycin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Josamycin Sales Market Share in Value by Type (2021-2026) Table 10. Global Josamycin Price by Type (2021-2026) & (US$/ton) Table 11. Global Josamycin Sales by Type (2027-2032) & (tons) Table 12. Global Josamycin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Josamycin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Josamycin Sales Market Share in Value by Type (2027-2032) Table 15. Global Josamycin Price by Type (2027-2032) & (US$/ton) Table 16. North America Josamycin Sales by Type (2021-2026) & (tons) Table 17. North America Josamycin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Josamycin Sales by Type (2021-2026) & (tons) Table 19. Europe Josamycin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Josamycin Sales by Type (2021-2026) & (tons) Table 21. Asia-Pacific Josamycin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Josamycin Sales by Type (2021-2026) & (tons) Table 23. Latin America Josamycin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Josamycin Sales by Type (2021-2026) & (tons) Table 25. Middle East and Africa Josamycin Sales by Type (2021-2026) & (US$ Million) Table 26. Josamycin Industry Trends Table 27. Josamycin Industry Drivers Table 28. Josamycin Industry Opportunities and Challenges Table 29. Josamycin Industry Restraints Table 30. Global Josamycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Josamycin Revenue Market Share by Company (2021-2026) Table 32. Global Josamycin Sales by Company (2021-2026) & (tons) Table 33. Global Josamycin Sales Share by Company (2021-2026) Table 34. Global Josamycin Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Josamycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Josamycin Major Company Production Sites and Headquarters Table 37. Global Josamycin Company, Product Type & Application Table 38. Global Josamycin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Josamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Josamycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Josamycin Sales by Region (2021-2026) & (tons) Table 43. Global Josamycin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Josamycin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Josamycin Sales Market Share in Value by Region (2021-2026) Table 46. Global Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Josamycin Sales by Region (2027-2032) & (tons) Table 48. Global Josamycin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Josamycin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Josamycin Sales Market Share in Value by Region (2027-2032) Table 51. Global Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Josamycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Josamycin Sales by Application (2021-2026) & (tons) Table 54. Global Josamycin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Josamycin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Josamycin Sales Market Share in Value by Application (2021-2026) Table 57. Global Josamycin Price by Application (2021-2026) & (US$/ton) Table 58. Global Josamycin Sales by Application (2027-2032) & (tons) Table 59. Global Josamycin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Josamycin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Josamycin Sales Market Share in Value by Application (2027-2032) Table 62. Global Josamycin Price by Application (2027-2032) & (US$/ton) Table 63. North America Josamycin Sales by Application (2021-2026) & (tons) Table 64. North America Josamycin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Josamycin Sales by Application (2021-2026) & (tons) Table 66. Europe Josamycin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Josamycin Sales by Application (2021-2026) & (tons) Table 68. Asia-Pacific Josamycin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Josamycin Sales by Application (2021-2026) & (tons) Table 70. Latin America Josamycin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Josamycin Sales by Application (2021-2026) & (tons) Table 72. Middle East and Africa Josamycin Sales by Application (2021-2026) & (US$ Million) Table 73. Tosun Pharm Company Information Table 74. Tosun Pharm Business Overview Table 75. Tosun Pharm Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Tosun Pharm Josamycin Product Portfolio Table 77. Tosun Pharm Recent Development Table 78. CSPC Company Information Table 79. CSPC Business Overview Table 80. CSPC Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. CSPC Josamycin Product Portfolio Table 82. CSPC Recent Development Table 83. SINE Company Information Table 84. SINE Business Overview Table 85. SINE Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. SINE Josamycin Product Portfolio Table 87. SINE Recent Development Table 88. Minsheng Pharma Company Information Table 89. Minsheng Pharma Business Overview Table 90. Minsheng Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Minsheng Pharma Josamycin Product Portfolio Table 92. Minsheng Pharma Recent Development Table 93. BioChemPartner Company Information Table 94. BioChemPartner Business Overview Table 95. BioChemPartner Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. BioChemPartner Josamycin Product Portfolio Table 97. BioChemPartner Recent Development Table 98. Guilin Pharma Company Information Table 99. Guilin Pharma Business Overview Table 100. Guilin Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Guilin Pharma Josamycin Product Portfolio Table 102. Guilin Pharma Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Bayer Josamycin Product Portfolio Table 107. Bayer Recent Development Table 108. Guanghua Pharma Company Information Table 109. Guanghua Pharma Business Overview Table 110. Guanghua Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Guanghua Pharma Josamycin Product Portfolio Table 112. Guanghua Pharma Recent Development Table 113. SAJA Pharma Company Information Table 114. SAJA Pharma Business Overview Table 115. SAJA Pharma Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. SAJA Pharma Josamycin Product Portfolio Table 117. SAJA Pharma Recent Development Table 118. Ferrer International Company Information Table 119. Ferrer International Business Overview Table 120. Ferrer International Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Ferrer International Josamycin Product Portfolio Table 122. Ferrer International Recent Development Table 123. Dragon Pharm Company Information Table 124. Dragon Pharm Business Overview Table 125. Dragon Pharm Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Dragon Pharm Josamycin Product Portfolio Table 127. Dragon Pharm Recent Development Table 128. Astellas Company Information Table 129. Astellas Business Overview Table 130. Astellas Josamycin Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 131. Astellas Josamycin Product Portfolio Table 132. Astellas Recent Development Table 133. North America Josamycin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 134. North America Josamycin Sales by Country (2021-2026) & (tons) Table 135. North America Josamycin Sales Market Share by Country (2021-2026) Table 136. North America Josamycin Sales Forecast by Country (2027-2032) & (tons) Table 137. North America Josamycin Sales Market Share Forecast by Country (2027-2032) Table 138. North America Josamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Josamycin Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Josamycin Market Share by Country (2021-2026) Table 141. North America Josamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Josamycin Market Share Forecast by Country (2027-2032) Table 143. Europe Josamycin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 144. Europe Josamycin Sales by Country (2021-2026) & (tons) Table 145. Europe Josamycin Sales Market Share by Country (2021-2026) Table 146. Europe Josamycin Sales Forecast by Country (2027-2032) & (tons) Table 147. Europe Josamycin Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Josamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Josamycin Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Josamycin Market Share by Country (2021-2026) Table 151. Europe Josamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Josamycin Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Josamycin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Josamycin Sales by Country (2021-2026) & (tons) Table 155. Asia-Pacific Josamycin Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Josamycin Sales Forecast by Country (2027-2032) & (tons) Table 157. Asia-Pacific Josamycin Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Josamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Josamycin Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Josamycin Market Share by Country (2021-2026) Table 161. Asia-Pacific Josamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Josamycin Market Share Forecast by Country (2027-2032) Table 163. Latin America Josamycin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 164. Latin America Josamycin Sales by Country (2021-2026) & (tons) Table 165. Latin America Josamycin Sales Market Share by Country (2021-2026) Table 166. Latin America Josamycin Sales Forecast by Country (2027-2032) & (tons) Table 167. Latin America Josamycin Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Josamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Josamycin Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Josamycin Market Share by Country (2021-2026) Table 171. Latin America Josamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Josamycin Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Josamycin Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Josamycin Sales by Country (2021-2026) & (tons) Table 175. Middle East and Africa Josamycin Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Josamycin Sales Forecast by Country (2027-2032) & (tons) Table 177. Middle East and Africa Josamycin Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Josamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Josamycin Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Josamycin Market Share by Country (2021-2026) Table 181. Middle East and Africa Josamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Josamycin Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Josamycin Distributors List Table 186. Josamycin Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Josamycin Image Figure 2. Global Josamycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Josamycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Josamycin Sales (2021-2032) & (tons) Figure 5. 99% Purity Type Image Figure 6. Global 99% Purity Type Sales YoY Growth (2021-2032) & (tons) Figure 7. 98% Purity Type Image Figure 8. Global 98% Purity Type Sales YoY Growth (2021-2032) & (tons) Figure 9. 95% Purity Type Image Figure 10. Global 95% Purity Type Sales YoY Growth (2021-2032) & (tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 13. Global Josamycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Josamycin Market Share by Type 2025 VS 2032 Figure 15. North America Josamycin Sales Market Share in Volume by Type in 2025 Figure 16. North America Josamycin Sales Market Share in Value by Type in 2025 Figure 17. Europe Josamycin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Josamycin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Josamycin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Josamycin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Josamycin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Josamycin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Josamycin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Josamycin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Josamycin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Josamycin Tablets Image Figure 28. Global Josamycin Tablets Sales YoY Growth (2021-2032) & (tons) Figure 29. Propidinium Propionate Granule Image Figure 30. Global Propidinium Propionate Granule Sales YoY Growth (2021-2032) & (tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Josamycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Josamycin Market Share by Application 2025 VS 2032 Figure 35. North America Josamycin Sales Market Share in Volume by Application in 2025 Figure 36. North America Josamycin Sales Market Share in Value by Application in 2025 Figure 37. Europe Josamycin Sales Market Share in Volume by Application in 2025 Figure 38. Europe Josamycin Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Josamycin Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Josamycin Sales Market Share in Value by Application in 2025 Figure 41. Latin America Josamycin Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Josamycin Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Josamycin Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Josamycin Sales Market Share in Value by Application in 2025 Figure 45. North America Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Josamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Josamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Josamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Josamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Josamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Josamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Josamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Josamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Josamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Josamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Josamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Josamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Josamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Josamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Josamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Josamycin Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Josamycin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 99% Purity Type
  • 98% Purity Type
  • 95% Purity Type
  • Others
Applications
  • Josamycin Tablets
  • Propidinium Propionate Granule
  • Others
Companies covered
  • Tosun Pharm
  • CSPC
  • SINE
  • Minsheng Pharma
  • BioChemPartner
  • Guilin Pharma
  • Bayer
  • Guanghua Pharma
  • SAJA Pharma
  • Ferrer International
  • Dragon Pharm
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Josamycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Josamycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Josamycin Market by Type
  6. 1.3.1 99% Purity Type
  7. 1.3.2 98% Purity Type
  8. 1.3.3 95% Purity Type
  9. 1.3.4 Others
  10. 1.4 Global Josamycin Market Size by Type
  11. 1.4.1 Global Josamycin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Josamycin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Josamycin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Josamycin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Josamycin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Josamycin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Josamycin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Josamycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Josamycin Industry Trends
  2. 2.2 Josamycin Industry Drivers
  3. 2.3 Josamycin Industry Opportunities and Challenges
  4. 2.4 Josamycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Josamycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Josamycin Sales (2021-2026)
  3. 3.3 Global Top Players by Josamycin Price (2021-2026)
  4. 3.4 Global Josamycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Josamycin Major Company Production Sites & Headquarters
  6. 3.6 Global Josamycin Company, Product Type & Application
  7. 3.7 Global Josamycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Josamycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Josamycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Josamycin Tier 1, Tier 2, and Tier 3
4 Josamycin Regional Status and Outlook
  1. 4.1 Global Josamycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Josamycin Historic Market Size by Region
  3. 4.2.1 Global Josamycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Josamycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Josamycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Josamycin Forecasted Market Size by Region
  7. 4.3.1 Global Josamycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Josamycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Josamycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Josamycin by Application
  1. 5.1 Josamycin Market by Application
  2. 5.1.1 Josamycin Tablets
  3. 5.1.2 Propidinium Propionate Granule
  4. 5.1.3 Others
  5. 5.2 Global Josamycin Market Size by Application
  6. 5.2.1 Global Josamycin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Josamycin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Josamycin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Josamycin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Josamycin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Josamycin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Josamycin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Josamycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tosun Pharm
  2. 6.1.1 Tosun Pharm Company Information
  3. 6.1.2 Tosun Pharm Business Overview
  4. 6.1.3 Tosun Pharm Josamycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tosun Pharm Josamycin Product Portfolio
  6. 6.1.5 Tosun Pharm Recent Developments
  7. 6.2 CSPC
  8. 6.2.1 CSPC Company Information
  9. 6.2.2 CSPC Business Overview
  10. 6.2.3 CSPC Josamycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Josamycin Product Portfolio
  12. 6.2.5 CSPC Recent Developments
  13. 6.3 SINE
  14. 6.3.1 SINE Company Information
  15. 6.3.2 SINE Business Overview
  16. 6.3.3 SINE Josamycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 SINE Josamycin Product Portfolio
  18. 6.3.5 SINE Recent Developments
  19. 6.4 Minsheng Pharma
  20. 6.4.1 Minsheng Pharma Company Information
  21. 6.4.2 Minsheng Pharma Business Overview
  22. 6.4.3 Minsheng Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Minsheng Pharma Josamycin Product Portfolio
  24. 6.4.5 Minsheng Pharma Recent Developments
  25. 6.5 BioChemPartner
  26. 6.5.1 BioChemPartner Company Information
  27. 6.5.2 BioChemPartner Business Overview
  28. 6.5.3 BioChemPartner Josamycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BioChemPartner Josamycin Product Portfolio
  30. 6.5.5 BioChemPartner Recent Developments
  31. 6.6 Guilin Pharma
  32. 6.6.1 Guilin Pharma Company Information
  33. 6.6.2 Guilin Pharma Business Overview
  34. 6.6.3 Guilin Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guilin Pharma Josamycin Product Portfolio
  36. 6.6.5 Guilin Pharma Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Josamycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Josamycin Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Guanghua Pharma
  44. 6.8.1 Guanghua Pharma Company Information
  45. 6.8.2 Guanghua Pharma Business Overview
  46. 6.8.3 Guanghua Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guanghua Pharma Josamycin Product Portfolio
  48. 6.8.5 Guanghua Pharma Recent Developments
  49. 6.9 SAJA Pharma
  50. 6.9.1 SAJA Pharma Company Information
  51. 6.9.2 SAJA Pharma Business Overview
  52. 6.9.3 SAJA Pharma Josamycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SAJA Pharma Josamycin Product Portfolio
  54. 6.9.5 SAJA Pharma Recent Developments
  55. 6.10 Ferrer International
  56. 6.10.1 Ferrer International Company Information
  57. 6.10.2 Ferrer International Business Overview
  58. 6.10.3 Ferrer International Josamycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ferrer International Josamycin Product Portfolio
  60. 6.10.5 Ferrer International Recent Developments
  61. 6.11 Dragon Pharm
  62. 6.11.1 Dragon Pharm Company Information
  63. 6.11.2 Dragon Pharm Business Overview
  64. 6.11.3 Dragon Pharm Josamycin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dragon Pharm Josamycin Product Portfolio
  66. 6.11.5 Dragon Pharm Recent Developments
  67. 6.12 Astellas
  68. 6.12.1 Astellas Company Information
  69. 6.12.2 Astellas Business Overview
  70. 6.12.3 Astellas Josamycin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astellas Josamycin Product Portfolio
  72. 6.12.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Josamycin Sales by Country
  2. 7.1.1 North America Josamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Josamycin Sales by Country (2021-2026)
  4. 7.1.3 North America Josamycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Josamycin Market Size by Country
  6. 7.2.1 North America Josamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Josamycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Josamycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Josamycin Sales by Country
  2. 8.1.1 Europe Josamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Josamycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Josamycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Josamycin Market Size by Country
  6. 8.2.1 Europe Josamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Josamycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Josamycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Josamycin Sales by Country
  2. 9.1.1 Asia-Pacific Josamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Josamycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Josamycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Josamycin Market Size by Country
  6. 9.2.1 Asia-Pacific Josamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Josamycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Josamycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Josamycin Sales by Country
  2. 10.1.1 South America Josamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Josamycin Sales by Country (2021-2026)
  4. 10.1.3 South America Josamycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Josamycin Market Size by Country
  6. 10.2.1 South America Josamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Josamycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Josamycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Josamycin Sales by Country
  2. 11.1.1 Middle East and Africa Josamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Josamycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Josamycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Josamycin Market Size by Country
  6. 11.2.1 Middle East and Africa Josamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Josamycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Josamycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Josamycin Value Chain Analysis
  2. 12.1.1 Josamycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Josamycin Production Mode & Process
  7. 12.2 Josamycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Josamycin Distributors
  10. 12.2.3 Josamycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst